Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Oxandrolone + glutamine for HIV-associated wasting

Sep. 25, 1997

BioChem Therapeutic synthesizes antiangiogenic fumagillin analogues

Sep. 24, 1997

Lilly presents structurally novel thrombin inhibitors

Sep. 24, 1997

BM-41.0904: a potential new osteoanabolic agent

Sep. 23, 1997

New SERMs prepared at Lilly

Sep. 23, 1997

Abbott searches for squalene synthase inhibitors as hypolipidemics

Sep. 23, 1997

Levormeloxifene preclinical and clinical data presented

Sep. 22, 1997

Eisai presents novel potential antipsychotic agent

Sep. 22, 1997

Highly selective 5-HT1D agonists described by MS&D

Sep. 22, 1997

Taisho/Nihon Nohyaku evaluate thiazole derivatives as antipsychotics

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...